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1. Introduction
  The genus Clerodendrum L. (Verbenaceae) is very 
widely distributed in tropical and sub-tropical regions 
of the world and is comprised of small trees, shrub sand 
herbs. This genus, with about 560 taxa, is the largest in 
the Verbenaceae and is taxonomically complex. Term 
Clerodendrum was named by Linnaeus in Species 
Plantarum in 1753[1]. The name is derived from two Greek 
words, kleros, meaning “chance or fate” and dendron, 
“a tree”[2]. The name so derived (Clerodendrum) has apt 
relevance to the considerable variation reported of its 
usefulness in medicine[3]. After a decade later, Adanson 
(1763) changed the Latin name “Clerodendrum” to its Greek 
form “Clerodendron”[4]; in Greek Klero means “chance” 
and dendron means “tree” i.e. chance tree, which means 
the tree that does not bring good luck. The reason for the 
genesis of the name to the genus is obscure but may well 
have relevance to the ancient belief that some species 
exhibited healing properties while, others had exactly 
opposite effects. Later, after a span of about two centuries
Moldenke (1942)[5] readopted the Latinized name 
‘Clerodendrum’, which is now commonly used by 
taxonomists for the classification and description of the 
genus and species[4,5,6]. 
2. Botanical description
  Clerodendron glandulosum .Coleb (CG; Family: 
Verbenaceae) is a shrub or a small tree, perennial, and 
wild or cultivated (Figure 1). Stem quadrangular, branches 
robust and sparsely pubescent with corky internodes. Young 
stem is shiny but turns light gray on maturity. Leaves are 
(1.5-28 cm) opposable, decussate, petiolate and long with 
prominent scars. Each leaf is broadly ovate, sub truncate or 
chordate at base, apex acute to acuminate, simple margin 
entire to slightly undulate, disagreeable small lateral veins 
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(6-9) with few glands clustered at the petiole and scattered 
beneath. Inflorescence is terminal, compact and corymbose 
cymes (30-60 cm long and up to 5 cm in diameter). 
Peduncles are robust, cylindrical (5-20 cm long), minutely 
pubescent and hollow. Flowers (0.4-2 cm) are pediculate, 
numerous, bracteates, white in colour and pedicelate (2-4 
cm). Bracts are lanceolate or narrowly ovate, caduceus at 
the time of flowering. One bract is present for each flower 
and glands are present on the lower surface. Calyx are 
gamosepalous, persistent, sepaloid, pubersent, campanulate 
with several peltate glands, sepals 5 (up to 0.4 cm long) and 
glandular. Teeth triangular, less than 0.1 cm, fruiting calyx, 
reddish purple (0.5-1 cm), corolla gamopealous, hypocrateri 
forms tube slander. Petals 5, white in colour, limps oblong 
or obovbate and acute at apex [0.5 cm 伊 (0.25-0.3 cm)]. 
Tube nearly glabrous (2.5-3 cm), stamen 4, didynamous, 
filiform, epipetalous exerted, glabrous and white (upto 
1.5 cm). Anthers are reddish or maroon, introse and 0.2 
cm long. Gynoecium (1.5 cm long) has exerted style and 
shorter than stamen with 4 loculi (due to the presence of 
false partitions). One locule is ovate in each loculus. Fruit 
is drupe, subglobose, glossy and bluish green in colour that 
turns black on drying[7]. 
Figure 1. Classification and digital photograph of CG taken from 
Imphal district, Manipur, India.
3. Traditional medicinal uses 
  The term “Kuthap” is a combination of “Ku” meaning 
a “wooden coffin” and “Thap”, “distant”, which literally 
means that a person using the plant as food or medicine is 
shielded or kept away from ills and ailments. It has a long 
association with the culture and tradition of Manipur since 
early 16th century[8]. The plant is used on many occasions 
by the people living both in the valley and hills. One such 
occasion is the Sajibu cheiraoba, the New Year day in 
Manipur calendar, in which the “kuthap” is an important 
ingredient used in the preparation of a special menu called 
“uti”, a naturally carbonated mixed vegetable pourice. 
Belief has it that, one taking uti on the first day of a year 
will endure long without any ailments until the end of the 
year. At the time of childbirth, the tribals use kuthap along 
with another plant called “kokan” to insure easy parturition 
for mother. The decoction of kuthap is soaked in a piece 
of cotton and inserted into the rectum of a child to expel 
worms out of the body. In other cases, kuthap finds usage in 
the preparation of natural hair care remedy locally known 
as chinghi, to kill lice. From the ancient times, belief has 
it that, a twig of kuthap hung on the wall of a room can 
protect from bugs carried in by bats. Traditionally, kuthap 
finds usage as medicine for lowering hypertension and for 
curing many skin diseases. Now, local markets sell kuthap 
for various purposes including household consumption as a 
food additive[9,10].
  Leaves of CG are used by Apatani and Nyishi tribes 
of North-East India as a therapeutic agent against 
hypertension[11,12] while, the tender shoots are used by the 
Debaru tribe for antipyresis[13]. Rural and urban people of 
Manipur (India) routinely grow CG in the kitchen garden 
with the leaves often sold in the market. Traditionally, cross 
sections of people across Manipur consume decoction of CG 
leaves for treating diabetes, obesity and hypertension[14]. 
4. Phytochemical constituents
  Phytochemical analysis of methanolic extract of CG 
revealed presence of phenols, steroids, alkaloids, 
anthraquinones, flavonoids and polyphenols while, tannins 
and terpenoids were absent[15]. Further, GC-MS analysis 
of CG hexane extract has demonstrated presence of 28 
compounds. Strongyloster, lupeol, n-hentriacontane and 
hexacosane represented 7%-13% each in hexane extract 
whereas, palmitic acid, vitamin E, 2-pentadecyn-1-ol, 
norolean-12-ene and octacosane were present in < 2%. 
5. Pharmacology
5.1. Antioxidant and free radical scavenging activity
  Reactive oxygen species and free radical-mediated 
reactions are known to be involved in degenerative or 
pathological processes such as aging, cancer, coronary 
heart disease and Alzheimer’s disease[16]. Natural 
antioxidants have gained wide popularity in lieu of its 
synthetic counterparts[17]. Methanolic extract of CG leaves 
(MECG) was assayed for its qualitative and quantitative 
phytochemical constituents as well as free radical 
scavenging potential using different in vitro assays for 
hydrogen peroxide, hydroxyl, superoxide, DPPH, nitric 
oxide, peroxynitrite, singlet oxygen and hypochlorous 
acid radicals. Its lipid peroxidation inhibitory activity, 
metal chelating activity and reducing power were also 
assayed. Qualitative phytochemical screening of MECG 
showed presence of polyphenols, steroids, flavanoids and 
saponins. Quantitative phytochemical analysis revealed 
(34.3依0.89) mg/mL gallic acid equivalent-polyphenols, 
(46.1依1.00) mg/mL quercetin equivalent-flavanoids and 
(53.36依0.93) mg/mL ascorbic acid per 100 mg MECG. The 
MECG scavenges hydrogen peroxide [IC50 (120.23依1.53) 毺g/mL],
hydroxyl [IC50 (70.23依1.36) 毺g/mL] superoxide [IC50 (80.36
依1.36) 毺g/mL], DPPH [IC50 (50.11依1.36 毺g/mL) and 
nitric oxide [IC50 (90.11依1.55) 毺g/mL] radicals in a dose 
dependent manner. The IC50 values for peroxynitrite, singlet 
oxygen and hypochlorous acid were (48.41依1.72), (62.15依
1.69) and (136.69依2.01) 毺g/mL respectively. MECG also 
inhibited lipid peroxidation [IC50 (150.56依3.02) 毺g/mL]
and promoted metal chelation [IC50 (50.29依2.00) 毺g/mL] 
in dose dependent manner. Assay of reducing capacity 
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of MECG showed a dose dependent response. This report 
suggests strong antioxidant activity of a methanolic extract 
of CG leaves against all known radicals and hence worthy of 
consideration as a natural antioxidant[15]. 
5.2. Hypolipidemic potential
  Saturated fats and/or cholesterol rich diet contribute 
to hypercholesterolemia and hypertriglyceridemia that 
progress to cardiovascular disorders[18]. Epidemiological and 
experimental studies have established the role of elevated 
plasma cholesterol in the development of atherosclerosis 
and other cardiovascular diseases[19]. In recent times, 
therapeutic approach for treatment of hyperlipidemia 
has shifted towards a combination therapy with synthetic 
drugs (i.e. niacin extended lovastatin release tablet), as 
cholesterol lowering drugs are having a moderate effect on 
triacylglyceride levels[20]. Another drawback of synthetic 
drugs is their inability to increase HDL levels[21]. Viewed 
in this context, the hypolipidemic potentials of medicinal 
plants need critical study. Several plant species with anti-
hypercholesterolemic potentials have found recognition[19]. 
Studies on the efficacy of aqueous extract of CG leaves on 
alteration in lipid and cholesterol metabolisms in high fat 
diet fed hyperlipidemic rats were undertaken. Rats were 
orally administered with CG extract (200, 400 or 800 mg/kg 
bodyweight) and fed with a standard laboratory diet (SLD) 
or high fat diet (HFD) for 6 weeks. Alterations in the plasma 
and hepatic lipid profiles, lipid and cholesterol metabolizing 
enzymes in target tissues, faecal total lipids and bile acid 
contents were evaluated in all the experimental groups. 
The results were compared with that of the synthetic 
hypolipidemic drug lovastatin. Results clearly indicated 
no alteration of any of the parameters tested in control 
rats for all the doses of CG employed. However, CG extract 
significantly prevented increment in plasma and tissue lipid 
profiles in HFD fed rats. Feeding with CG extract significantly 
suppresses activity levels of HMG CoA reductase (Hepatic) 
and cholesterol ester synthase (Hepatic and intestinal) and 
increases the activity levels of plasma lecithin cholesterol 
acyl transferase and lipoprotein lipase (plasma, hepatic 
and adipose). Further, feeding of HFD rats with CG extract 
increased excretion of triglycerides, cholesterol and bile 
acids through faeces. These results suggest reduced 
absorption, effective elimination and augmented catabolism 
of lipids and cholesterol, possibly accreditable to high 
content of saponin and phytosterols in CG. Therapeutic 
potential of CG extract against hypercholesterolemia and 
hypertriglyceridemia was projected for the first time through 
the data published in this report[22]. 
5.3. Prevention of metabolic syndrome
  A conglomerate of glucose intolerance, dyslipidemia 
and hypertension is known as metabolic syndrome 
(MetS)[23]. Of late, MetS has become one of the major 
public health challenges worldwide[24]. Feeding rats 
with fructose (FRU) rich diet is known to develop 
experimental hypertension accompanied by the metabolic 
abnormalities of hyperinsulinemia, insulin resistance and 
hyperlipidemia[25], which has led to consideration of this as 
an ideal experimental model for pre-clinical evaluation of 
various therapeutic agents against MetS[26]. Protective effect 
of an aqueous extract of CG leaves against FRU induced 
metabolic syndrome was evaluated in male Charles foster 
rats. Experimental metabolic syndrome was induced by 
feeding with 60% FRU rich diet. Changes in bodyweight, 
food and fluid intake, plasma glucose, insulin, fasting 
insulin resistance index (FIRI), plasma total lipid profile, 
free fatty acids (FFA), oral glucose tolerance (OGTT), blood 
pressure and vascular reactivity were all investigated in 
Control (rats fed with laboratory chow for 8 weeks), FRU 
(rats fed with FRU rich diet for 8 weeks) and FRU+CG (rats 
fed with FRU rich diet and orally administered with 200 or 
400 mg/kg of CG extract for 8 weeks) groups. FRU+CG groups 
recorded significant decrement (P<0.05) in plasma glucose, 
insulin, FIRI and lipid profile while, plasma HDL level was 
significantly increased (P<0.05) along with an efficient 
clearance of glucose as revealed by tolerance curve and 
area under the curve value.  FRU+CG groups also recorded 
significantly decreased (P<0.05) mean arterial blood pressure 
along with decreased vasoconstriction and increased 
vasorelaxation in response to administration of various 
pharmacological agents. These results were comparable with 
those of metformin treated rats. This report surmises the 
role of CG extract in ameliorating experimentally induced 
insulin resistance and hypertension and provides the first 
pharmacological evidence for protective role of CG leaves 
against experimentally induced metabolic syndrome[27]. 
5.4. Amelioration of non alcoholic steatohepatitis
  Non-alcoholic steatohepatitis (NASH) is a pathological 
condition characterized by accumulation of lipids in the 
liver of non-alcoholic individuals and consequent oxidative 
stress leading to cirrhosis of liver in the long run[28]. 
Most of the synthetic lipid lowering drugs are efficient 
in management of hyperlipidemia and obesity but, are of 
negligible therapeutic value against NASH[29]. Hence, it is 
a major challenge for pharmaceutical industry to develop 
a combination therapy that is effective against NASH in 
obese and IR individuals. Herbal medicines are becoming 
increasingly popular and being looked up to for management 
of hyperlipidemia, obesity and IR, primarily because of their 
minimal side effects and their multiple modes of action in 
controlling lipid metabolism[22]. Protective role of aqueous 
extract of CG leaves against high fat diet/fatty acid induced 
lipotoxicity in C57BL/6J mice and oleic acid treated HepG2 
cells have been used as experimental models of NASH[30]. 
Plasma lipid profile, markers of hepatic damage, hepatic 
mitochondrial reactive oxygen species, markers of oxidative 
stress and antioxidants and histopathological changes were 
evaluated in CON (mice fed with low fat diet for 16 weeks), 
NASH (mice fed with HFD for 16 weeks) and NASH+CG1 and 
NASH+CG3 (mice fed with HFD containing 1 and 3% CG
extract(w/w)for 16 weeks). Supplementation of NASH mice 
with CG extract significantly prevented HFD induced 
elevation in plasma markers of liver damage, plasma 
and hepatic lipids, mitochondrial oxidative stress and 
compromised enzymatic and non-enzymatic antioxidant 
status and histopathological damage to hepatocytes. 
Furthermore, results from in vitro study indicated attenuation 
of oleic acid induced lipid accumulation in HepG2 cells in 
presence of CG extract. Moreover, addition of CG extract 
(20-200 毺g/mL for 24 h) to HepG2 cells significantly 
minimized lipid peroxidation and cytotoxicity and increased 
cell viability. These in vivo and in vitro studies were the 
first comprehensive experimental evidences that establish 
the potency of CG extract in preventing high fat/fatty acid 
induced NASH[30]. 
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5.5. Anti-obesity potential
  Obesity, initially thought as a problem of the developed 
world, has now become a worldwide malady because 
of increasing prevalence in the developing countries 
as well[31]. Due to the high costs and the potentially 
hazardous side-effects of synthetic drugs, the potential of 
natural products for treating obesity is under exploration 
currently[32,33]. In this behest, traditional herbal medicines 
and food ingredients capable of controlling weight gain 
are in vogue[34]. Effects of CG extract on (i) expression of 
genes regulating visceral adiposity in HFD fed C57BL/6J 
mice and (ii) in vitro 3T3L1 pre-adipocyte differentiation 
and leptin release were also investigated. Changes in 
body weight, lee index, plasma lipids and leptin, mRNA 
expression of peroxisome proliferator-activated receptor 
gamma isoform 2 (PPAR毭-2), sterol regulatory element 
binding proteins isoform 1c (SREBP1c), fatty acid synthase 
(FAS), carnitine parmitoyltransferase-1 (CPT-1) and leptin 
in epididymal adipose tissue of LEAN (mice fed with LFD 
for 20 weeks),  OB (mice fed with HFD for 20 weeks) and 
OB+CG (mice fed with HFD containing 1% (w/w) CG extract 
for 20 weeks) were also investigated. Further assessed was 
the potential of CG extract on in vitro 3T3L1 pre-adipocyte 
differentiation and LEP release. Supplementation of HFD fed 
mice with CG extract significantly prevented HFD induced 
increment in bodyweight, lee index, plasma lipids and LEP, 
visceral adiposity and adipocyte hypertrophy. Further, 
supplementation with CG extract resulted in down regulation 
of PPAR毭-2, SREBP1c, FAS and leptin expressions 
along with up-regulation of CPT-1 in epididymal adipose 
tissue compared to HFD fed mice. In vitro study recorded 
significant anti-adipogenic effect of CG extract marked 
by decreased adipogenesis, TG accumulation, leptin 
release and Glyceraldehyde 3-phosphate dehydrogenase 
(G3PDH) activity along with higher glycerol release without 
significantly altering viability of 3T3L1 pre-adipocytes. This 
inventory was a profound scrutiny of CG extract and its role 
in preventing adipocyte differentiation and visceral adiposity 
by down regulation of PPAR毭-2 related genes and leptin 
expression. This study validates the traditional therapeutic 
claim of use of CG extract in controlling obesity[35]. 
5.6. Prevention of in vitro low density lipoprotein (LDL) 
oxidation and macrophage apoptosis
  During the last decade, LDL oxidation and LDL particle 
size have received extensive attention for their atherogenic 
potentials[36]. Secondly, oxidized LDL (Ox-LDL) stimulates 
endothelium to secrete monocyte chemotactic protein-1 
(MCP-1) from endothelial cells, which facilitate infiltration 
of monocytes into the sub-endothelial space[37]. Oxidized 
LDL can also induce migration and proliferation of smooth 
muscle cells and impede endothelial cell migration. 
Oxidized LDL promotes the differentiation of macrophage 
colony stimulating factor from endothelial cells and inhibits 
the motility of resident macrophage[38]. Studies have reported 
that Ox-LDL is cytotoxic to various cell types present in an 
artery and can induce macrophage apoptosis after being 
internalized via scavenger receptors[39]. Protective role 
of CG extract against in vitro LDL oxidation and Ox-LDL 
induced macrophage apoptosis were studied using various 
in vitro experimental models. Effect of CG extract on cell 
free (Cu2+ mediated) and cell mediated (macrophage) LDL 
oxidation and formation of various intermediary products 
were investigated. Ox-LDL induced macrophage apoptosis 
was evaluated by nuclear condensation, cell cycle analysis, 
and annexinV-FITC/propidium iodide staining in presence 
or absence of CG extract. Data shown in this report hints at 
the protective role of CG extract against LDL oxidation, Ox-
LDL induced macrophage oxidative stress, mitochondrial 
dysfunction and apoptosis. Thus, the modulatory role of CG 
extract on two key events of atherosclerosis contributing 
to its anti-atherogenic potential and subsequent use as a 
possible herbal medicine stand reported[40]. 
5.7. Amelioration of experimental atherosclerosis
  Anti-atherogenic potential of CG leaf extract was 
evaluated using in vivo and in vitro experimental models. 
Serum markers of LDL oxidation, cholesterol, triglycerides, 
lipoproteins and auto-antibody titter, ex vivo LDL oxidation, 
LDL aggregation, aortic lipids and histopathological 
evaluations along with immunolocalization of macrophage 
surface marker (F4/80), vascular cell adhesion molecule-1 
(VCAM-1) and P-selectin were all evaluated  in CON 
(rats treated with single dose of saline (i.p.) and fed with 
laboratory chow), ATH (rats treated with single dose of 
vitamin D3 (600 000 IU, i.p) and fed with atherogenic diet) 
and ATH+CG (rats treated with single dose of vitamin 
D3 (600 000 IU, i.p.), fed with atherogenic diet and 
simultaneously treated with 200 mg/kg CG extract, p.o.) 
for 8 weeks. Supplementation of atherogenic diet fed 
rats with CG extract significantly prevented increment 
in serum cholesterol, triglycerides, and lipoproteins, 
markers of LDL oxidation, auto-antibody titter and 
aortic lipids. Moreover, LDL isolated from ATH+CG rats 
recorded minimal aggregation and susceptibility to 
undergo ex vivo LDL oxidation. Microscopic evaluation 
of thoracic aorta of ATH+CG rats revealed prevention of 
atheromatous plaque formation, accumulation of lipid 
laden macrophages, calcium deposition, distortion/
defragmentation of elastin, accumulation of macrophages 
and, down regulation of cell adhesion molecule (VCAM-1 
and P-selectin) expression. Further, in vitro monocyte to 
macrophage differentiation was significantly attenuated in 
presence of CG extract (200 毺g/mL). It can be concluded
from the p2resent study that, CG extract is capable of 
controlling induction of experimental atherosclerosis and 
warrants further scrutiny at the clinical level as a possible 
therapeutic agent[41-46]. 
5.8. Hepatoprotective potential
  Various hepatic ailments are responsible for billions of 
deaths worldwide[47]. Further, synthetic therapeutic drug 
induced hepatic injury is also a serious concern of modern 
day pharmacists and scientists worldwide. In this behest, 
use of herbal agents to prevent various hepatic ailments 
and drug induced hepatotoxicity is in vogue. Various 
herbal extracts in this context have been screened for their 
possible hepatoprotective potentials. Hepatoprotective 
potential of CG extract in experimental model of carbon 
tetrachloride (CCl4) induced hepatotoxicity in male rats 
was investigated. Changes in plasma marker enzymes 
of hepatic damage, total bilirubin content, hepatic lipid 
peroxidation, enzymatic and non-enzymatic antioxidants 
and histopatholgical alterations were evaluated in various 
experimental groups. Rats pre-treated with CG extract 
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(400 mg/kg for 15 days) followed by administration of CCl4 
(0.5 mL/kg on 16th day) recorded significant decrement in 
plasma marker enzymes of hepatic damage, total bilirubin 
content and hepatic lipid peroxidation. In addition, contents 
of hepatic reduced glutathione, ascorbic acid and plasma 
total protein and activity levels of superoxide dismutase and 
catalase showed significant increase in the same animals. 
Microscopic examination of liver depicted prevention of 
CCl4 induced hepatic damage by pre-treatment with CG. In 
conclusion, this report summarises the potency of CG extract 
in maintaining cellular integrity of hepatocytes, as denoted 
by the serum levels markers of hepatic damage, and hence 
its hepatoprotective efficacy[48]. 
6. Toxicity evaluation
  During the past few decades, use of herbal medicines has 
witnessed a phenomenal upswing not only in developing 
countries but also in developed countries[49]. World 
health organization has also recommended use of herbal 
medicines against diseases for which synthetic drugs are not 
available[50]. Further, the awareness of possible multifocal 
potentials of various herbal drugs has opened a flood gate 
of investigative therapy against metabolic disorders, where 
multiple complications coexist[22]. However, use of herbal 
drugs is still limited because of their consideration as either 
dietary supplements or as food additives instead of as drugs 
as per the US-FDA criteria[51] and hence, their rigorous 
safety evaluation is not a routine practice[48]. Moreover, 
adverse effects of various herbal extracts have found 
mention and hence, preclinical toxicological evaluation of 
herbal extracts is warranted for a better acceptance. Acute 
and sub-chronic toxicological evaluations of aqueous 
extract CG leaves were carried out using Swiss albino mice. 
Acute (single administration of 1 000, 2 000, 3 000, 4 000 or 
5 000 mg/kg) and sub-chronic (750, 1 500 or 3 000 mg/kg for 
28 days) toxicity tests were performed as per the guideline 
of Organisation for Economic Cooperation and Development 
(OECD). No mortality was recorded in animals that were 
orally administered up to 5 000 mg/kg of extract. There were 
also no adverse behavioural changes, diarrhoea, salivation or 
food aversion. Sub-chronic doses of CG extract showed no 
significant effect on plasma contents of electrolytes, glucose, 
urea, creatinine, total protein and activity levels of acid 
phosphatase, alkaline phosphatase, aspartate transaminase and 
alanine transaminase up to a dose of 3 000 mg/kg bodyweight. 
Acute and sub-chronic toxicity tests reveal CG extract to 
be non-toxic with a lethal dose (LD50) value > 5 000 mg/kg
bodyweight and no significant alterations in the biochemical 
profile[48]. 
7. Conclusion and further scope
  To sum up, the review presents an up to date finding 
providing scientific validity to the traditional practice of 
using CG as a folklore medicine. The leaf extract is reliably 
non toxic with strong anti oxidant properties. It shows 
efficacy against experimentally induced hypertension, 
insulin resistance and obesity. Besides, it also shows 
very favourable responses befitting its possible use as a 
phytotheraputant against NASH. 
  Based on our detailed study on CG extract reviewed above, 
future lines of investigation seem appropriate to generate 
better and focussed understanding of the therapeutant 
properties of CG. In this behest following investigations 
should be carried out: 
1. Effects of CG extract in amelioration of type I diabetes.
2. To carry forward the finding to its logical conclusion, 
isolation and characterization of active principles is 
warranted.
3. In keeping with the folklore usage, its antipyretic and 
antihelminthic action needs to be ascertained.
4. Molecular mechanism of CG mediated easing of insulin 
resistance needs to be understood.
5. With effective scientific validation obtained in 
experimental models, the revealed therapeutic potential 
of CG extract needs to be carried forward to the level of 
clinical testing and possible usage as anti- obesity/anti-
hypertensive medication. 
Conflict of interest statement
  Authors declare no conflict of interest.
Acknowledgements
  Mr. Ravirajsinh N Jadeja wish to acknowledge Council 
of Scientific and Industrial  Research (CSIR), New Delhi, 
INDIA for providing financial assistant in the form of CSIR-
Senior Research Fellowship (Award No. 09/114/(0179)/2011/
EMR-1). 
References
[1]   Anonymous. Clerodendrum. In: Carolus Linnaeus. Species 
Plantarum 1753; 2: 637.
[2]   Quattrocchi U. CRC world dictionary of plant names. Boca Raton: 
CRC Press; 2000, p. 559. 
[3]   Mabberley DJ. Mabberley’s plant-book. 3rd ed. Cambridge: 
Cambridge University Press; 2008.
[4]   Shrivastava N, Patel T. Clerodendrum and healthcare: an 
overview. Medicinal Aromatic Plant Sci Biotech 2007; 1: 142-150.
[5]   Moldenke HN. Notes on the genus Clerodendrum (Verbenaceae) 
IV. Phytologia 1985; 57: 334-365.
[6]   Rueda RM. The genus Clerodendrum (Verbenaceae) in 
Mesoamerica. Ann Missouri Bot Garden 1993; 80: 870-890.
[7]   Deb DB. Flora of Tripura State. New Delhi: Today and Tomorrow’s 
Printers; 1983, p. 107. 
[8]   Anonymous. Hidaklon-book of traditional medicine, an archaic 
literature 16th century.  Imphal: Chandrasingh Memorial 
Manuscript Library.
[9]   Anonymous. Leirol, book of flowers, an archaic literature 17th 
century. Imphal: Chandrasingh Memorial Manuscript Library.
[10] Anonymous. Leirol, lumbuba, book of flowers, an archaic literature 
17th century. Imphal: Chandrasingh Memorial Manuscript, 
Library.
[11] Kala CP. Ethnomedicinal botany of the Apatani in the Eastern 
Himalayan region of India. J Ethnobiol Ethnomed 2005; 1: 11.
[12] Deb S, Arunachalam A, Das AK. Indigenous knowledge of Nyishi 
tribes on traditional agro forestry systems. Indian J Trad Knowl 
2009; 8: 41-46.
[13] Jubilee P, Subhan CN, Islamb M. Ethnobotany of medicinal 
plants from Dibru-Saikhowa biosphere reserve of Northeast India. 
Fitoterapia 2005; 76: 121-127.
Ravirajsinh N Jadeja et al./Asian Pacific Journal of Tropical Medicine (2012)1-66
[14] Jadeja RN, Thounaojam MC, Ansarullah, Devkar RV, 
Ramchandran AV. A prelimnary study on hypolipidemic effect of 
aqueous extract of Clerodendron glandulosum. Coleb.  Int J Green 
Pharm 2009; 2: 119-123.
[15] Jadeja RN, Thounaojam MC, Ansarullah, Ramchandran AV, 
Devkar RV. Phytochemical constituents and free radical 
scavenging activity of Clerodendron glandulosum Coleb 
methanolic extract. J Compl Integr Med 2009; 6: 1-23. 
[16] Bandyopadhyay U, Das D, Banerjee RK. Reactive oxygen species: 
oxidative damage and pathogenesis. Curr Sci 1999; 77: 5.
[17] Thounaojam MC, Jadeja RN, Devkar RV, Ramachandran 
AV. Antioxidant and free radical scavenging activity of Sida 
rhomboidea. Roxb methanolic extract determined using different 
in vitro models. Bol Latinoam Caribe Plant Med Aromat 2010; 9: 
191-198.
[18] Al-Attar AM. Physiological and biochemical alterations in 
Sprague-Dawley female rats subjected to high fat diet and 
intermittent fasting. J Appl Sci Res 2010; 6: 2096-2104.
[19] Mukerjee PK. Plant products with hypocholesterolemic potentials. 
In: L. Taylor (ed). Advances in food and nutrition research. 
Netherlands: Elsevier; 2003, p. 278-339.
[20] Richard NF. Statin drugs. [Online]. Available from: http://
heartdisease.about.com/b/2008/01/14/enhance-at-best-no-
benefit-from-vytorinor-zetia.htm. [Accessed on 2008].
[21] Wilson PWF. High density lipoprotein, low density lipoprotein 
and coronary heart disease. Am J Cardiol 1990;  66: 7-10.
[22] Jadeja RN, Thounaojam MC, Ansarullah, Devkar RV, 
Ramchandran AV. Clerodendron glandulosum  Coleb. 
Verbenaceae, ameliorates high fat diet-induced alteration in 
lipid and cholesterol metabolism in rats. Revista Brasileira de 
Pharmacognosia 2010; 20: 117-123.
[23] Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC. Definition of 
metabolic syndrome report of the National Heart, Lung, and Blood 
Institute/American Heart Association Conference on scientific 
issues related to definition. Circulation 2004; 109: 433-438.
[24] Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. 
Lancet 2005; 365: 1415-1428.
[25] Basciano H, Federico L, Adeli K. Fructose, insulin resistance, and 
metabolic dyslipidemia. Nutr Metab 2005; 2: 5.
[26] Mohammd RS, Mehdi H, Ahamd RS. Prevention of high fructose-
induced metabolic syndrome in male wistar rats by aqueous 
extract of Tamarindus Indica seed. Acta Medica Iranica 2011; 49: 
5.
[27] Jadeja RN, Thounaojam MC, Ansarullah, Patel VB, Devkar RV, 
Ramachandran AV. Protective effect of Clerodendron glandulosum 
extract against experimentally induced metabolic syndrome in 
rats. Pharm Biol 2010; 48: 1312-1319.
[28] Duvnjak M, Lerotić I, Baršić N, Tomašić V, Jukić LV, Velagić V. 
Pathogenesis and management issues for non-alcoholic fatty liver 
disease. World J Gastroenterol 2007; 13: 4539-4550.
[29] Nakamoto K, Takayama F, Mankura M, Hidaka Y, Egashira T, 
Ogino T, et al. Beneficial-effects of fermented green tea extract in 
a rat model of non-alcoholic steatohepatitis. J Clin Biochem Nutr 
2009; 44: 239-246.
[30] Jadeja RN, Thounaojam MC, Dandekar DS, Devkar RV, 
Ramachandran AV. Clerodendron glandulosum.Coleb extract 
ameliorates high fat diet/fatty acid induced lipotoxicity in 
experimental models of non alcoholic steatohepatitis. Food Chem 
Toxicol 2010; 48: 3424-3431.
[31] Hoffman DJ. Obesity in developing countries: causes and 
implications. Food Nutr Agric 2001; 28: 35-44. 
[32] Nakayama T, Suzuki S, Kudo H, Sassa S, Nomura M, Sakamoto 
S. Effects of three Chinese herbal medicines on plasma and liver 
lipids in mice fed a high-fat diet. J Ethnopharmacol 2007; 109: 
236-240.
[33] Mayer MA, Hocht C, Puyo A, Taira CA. Recent advances in 
obesity pharmacotherapy. Curr Clin Pharmacol 2009; 4: 53-61
[34] Yun JW. Possible anti-obesity therapeutics from nature-a review. 
Phytochemistry 2010; 71: 1625-1641.
[35] Jadeja RN, Thounaojam MC, Ramani UV, Devkar RV, 
Ramachandran AV. Anti-obesity potential of Clerodendron 
glandulosum. Coleb leaf aqueous extract. J Ethnopharmacol 2011; 
135: 338-343.
[36] Libby P, Ridker PM, Hansson GK. Progress and challenges in 
translating the biology of atherosclerosis. Nature 2011; 473: 
317-325.
[37] Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, 
Parhami F, et al. Minimally modified low density lipoprotein 
induces monocyte chemotactic protein 1 in human endothelial 
cells and smooth muscle cells. Proc Natl Acad Sci USA 1999; 87: 
5134-5138.
[38] Stocker R, Keaney JF Jr. Role of oxidative modifications in 
atherosclerosis. Physiol Rev 2004; 84: 1381-1478.
[39] Boullier A, Bird DA, Chang MK, Dennis EA, Friedman P, 
Gillotre-Taylor K, et al. Scavenger receptors, oxidized LDL, and 
atherosclerosis. Ann N Y Acad Sci 2001; 947: 214-222.
[40] Jadeja RN, Thounaojam MC, Devkar RV, Ramachandran AV. 
Clerodendron glandulosum.Coleb extract prevents in vitro human 
LDL oxidation and oxidized LDL induced Apoptosis in human 
monocyte derived macrophages. Food Chem Toxicol 2011; 49: 
1195-1202.
[41] J a d e j a  R N ,  T h o u n a o j a m  M C ,  J a i n  M ,  D e v k a r  R V , 
Ramachandran AV. Clerodendron glandulosum.Coleb leaf 
extract attenuates in vitro macrophage differentiation and 
expression of VCAM-1 and P-selectin in thoracic aorta of 
atherogenic diet fed rats. Immunopharm Immunotox 2011; DOI: 
10.3109/08923973.2011.618136.
[42] Lodhi S, Singhai AK. Preliminary pharmacological evaluation of 
Martynia annua Linn leaves for wound healing. Asian Pac J Trop 
Biomed 2011; 1(6): 421-427.
[43] Paul KR, Irudayaraj V, Johnson M, Patric DR. Phytochemical and 
anti-bacterial activity of epidermal glands extract of Christella 
parasitica (L.) H. Lev. Asian Pac J Trop Biomed 2011; 1(1): 8-11.
[44] Mithraja MJ, Antonisamy JM, Mahesh M, Paul ZM, Jeeva S. 
Phytochemical studies on Azolla pinnata R. Br., Marsilea minuta 
L. and Salvinia molesta Mitch. Asian Pac J Trop Biomed 2011; 
1(Suppl 1): S26-S29.
[45] Kiruba S,  Mahesh M, Paul ZM, Jeeva S.  Preliminary 
phytochemical screening of the pericarp of Crataeva magna 
(Lour.) DC. - a medicinal tree. Asian Pac J Trop Biomed 2011; 
1(Suppl 1): S129-S130.
[46] Kiruba S, Mahesh M, Nisha SR, Paul ZM, Jeeva S. Phytochemical 
analysis of the flower extracts of Rhododendron arboreum Sm. 
ssp. nilagiricum (Zenker) Tagg. Asian Pac J Trop Biomed 2011; 
1(Suppl 2): S284-S286.
[47] Williams R. Global challenges in liver disease. Hepatology 2006; 
44: 521-526.
[48] Jadeja RN, Thounaojam MC, Ansarullah, Jadav SV, Patel MD, 
Patel DK, et al. Toxicological evaluation and hepatoprotective 
potential of Clerodendron glandulosum Coleb leaf extract. Hum 
Exp Toxicol 2011; 30: 63-70.
[49] Verma S, Singh SP. Current and future status of herbal medicines. 
Veterinary World 2010; 1: 347-350
[50] WHO. Traditional herbal remedies for primary health care. 
[Online]. Available from: http://apps.who.int/bookorders/anglais/
detart1.jsp?sesslan=1&codlan=1&codcol=54&codcch=18. 
[Accessed on 2010].
[51] Mosihuzzaman M, Choudhary MI. Protocols on safety, efficacy, 
standardization, and documentation of herbal medicine. Pure Appl 
Chem 2008; 80: 2195-2230.
